Showing results (111-120 of 283) with videos related to

Sort By:
Pageof 29
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 26, 2017
Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosisYuko Nagaoki, Hiroshi Aikata, Kana Daijyo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 14, 2011
Recent trend of clinical features in patients with hepatocellular carcinomaYuko Nagaoki, Hideyuki Hyogo, Hiroshi Aikata, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 4, 2009
Successful hepatitis B vaccination in liver transplant recipients with donor-specific hyporesponsivenessHiroyuki Tahara, Yuka Tanaka, Kohei Ishiyama, et al.
Oncology|March 1, 2017
Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with SorafenibTomokazu Kawaoka, Hiroshi Aikata, Yuji Teraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 3, 2014
Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantationTomokazu Kawaoka, Shoichi Takahashi, Yumiko Tatsukawa, et al.
Journal of Gastroenterology and Hepatology|March 22, 2012
Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantationTomokazu Kawaoka, Shoichi Takahashi, Shintaro Takaki, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|May 8, 2009
[Case of double cancer of the liver, cholangiocarcinoma and hepatocellular carcinoma detected in a patient with hepatitis C 13 years after diminution of HCV-RNA by interferon treatment]Takako Tsumura, Shintaro Takaki, Hiroshi Aikata, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 1, 2009
Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infectionHiromi Abe, Hidenori Ochi, Toshiro Maekawa, et al.
The Journal of Infectious Diseases|September 22, 2016
Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep SequencingHiromi Kan, Michio Imamura, Takuro Uchida, et al.
World Journal of Gastroenterology|September 19, 2007
Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinomaSoocheol Jeong, Hiroshi Aikata, Yoshio Katamura, et al.
Pageof 29